vimarsana.com

Page 25 - தேசிய மருந்துகள் ஒழுங்குமுறை அதிகாரம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Sri Lankan shares end at record high on optimism over AstraZeneca s virus vaccine nod

By Reuters Staff 2 Min Read Jan 22 (Reuters) - Sri Lankan shares closed at a record high on Friday, helped by gains in financial and consumer staples stocks, and as investors cheered the country’s drug regulator giving emergency use approval to AstraZeneca’s COVID-19 vaccine. The benchmark stock index ended up 4.09% at 8,463.43. The index gained 9.4% for the week, its best weekly performance since May 2009. Sri Lanka’s National Medicines Regulatory Authority gave regulatory clearance for emergency use of AstraZeneca’s COVID-19 vaccine, state minister Channa Jayasumana told reporters in Colombo. The island nation will receive shipments of the vaccine from India, though the exact date is unknown.

India Welcomes Sri Lanka s Emergency Use Approval of Covishield Vaccine Against Covid-19

1-MIN READ India Welcomes Sri Lanka s Emergency Use Approval of Covishield Vaccine Against Covid-19 A health official shows a Covishield vaccine dose, after a consignment of the vaccine arrived from Serum Institute of India, in Tezpur (PTI Photo) Nepal, Bangladesh, Bhutan and the Maldives have already received India s COVID-19 vaccines under grant assistance in sync with its Neighbourhood First policy. FOLLOW US ON: India has welcomed Sri Lanka s emergency use approval of Covishield vaccine which is being manufactured by the Serum Institute of India. Nepal, Bangladesh, Bhutan and the Maldives have already received India s COVID-19 vaccines under grant assistance in sync with its Neighbourhood First policy.

UNCERTAINTY SURROUNDING COVID VACCINE TO SL

UNCERTAINTY SURROUNDING COVID VACCINE TO SL UNCERTAINTY SURROUNDING COVID VACCINE TO SL Written by Share: Colombo (News 1st); The Presidential Task Force handling Sri Lanka’s COVID-19 Vaccination Plan said it is still uncertainty when the island will be receiving COVID-19 vaccines from India. India has begun the exportation of its Oxford-AstraZeneca vaccine manufactured by the Serum Institute under the name Covishield among neighbouring states. The State Pharmaceuticals Corporation has not granted clearance for the local agent of the Indian vaccine manufacturer to supply the Covishield jab to Sri Lanka. The State Pharmaceuticals Corporation’s General Manager K.M.D.R. Dissanayake said discussions are taking place with a private company that acts as a local agent of India’s Serum Institute.

SL submits documents to obtain India s vaccines : NMRA

COLOMBO (News1st): Sri Lanka has submitted documents to obtain COVID-19 vaccines from India, the National Medicines Regulatory Authority (NMRA) has said. - Get the latest breaking news and top stories from Sri Lanka, the latest political news, sports news, weather updates, exam results, business news, entertainment news, world news and much more from News 1st, Sri Lanka's leading news network.

LankaWeb – Covid-19 vaccine equivalent Sinhala Wedakam physician achieves international fame

Posted on January 17th, 2021 Courtesy The Sunday Observer A medical heritage of a country could be cited as one of its best treasures and most powerful weapons. Sri Lanka has proven that its medical legacy was protected by ancient kings as part of governance policy and aspects, such as agriculture, belief system/spirituality and diet encompassing the concept of health. We can only imagine that if there was a ‘Ministry of Health’ as we have today, in ancient times, how it would have been integrated to ensure the optimum health of its citizens; through what we cultivate, how we cultivate it, through hydraulic sustainability to prevent hunger, disease and being indebted to other countries for essentials, such as medicine and food.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.